Patents Examined by Claresse Evans
  • Edelfosin for the treatment of brain tumors
    Patent number: 6514519
    Abstract: Octadecyl-2-methyl-sn-glycero-3-phosphocholine (edelfosine) is suitable for the treatment of brain tumors and can therefore be used to produce a drug for the treatment of brain tumors which can also be administered orally.
    Type: Grant
    Filed: January 25, 2001
    Date of Patent: February 4, 2003
    Assignee: Med-Mark Pharma GmbH
    Inventor: Apollonia Nagler
  • Aspartic and malic acid inhibition of ss-glucuronidase
    Patent number: 6416783
    Abstract: Disclosed herein are infant dietary supplements containing L-aspartic and/or L-malic acid. The supplements are designed to inhibit &bgr;-glucuronidase activity in breast feeding babies, and thereby suppress serum bilirubin levels and the incidence of neonate jaundice. In one form L-aspartic acid is mixed with human breast milk and fed to the neonate on the same schedule that breast feeding would otherwise normally occur. In another form the L-aspartic acid is delivered in an aqueous solution supplemented with sodium and potassium.
    Type: Grant
    Filed: August 18, 2000
    Date of Patent: July 9, 2002
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Glenn R. Gourley, Bill L. Kreamer